Literature DB >> 31806198

Measuring Productivity Costs in Patients With Musculoskeletal Disorders: Measurement Properties of the Institute for Medical Technology Assessment Productivity Cost Questionnaire.

Rikke Munk1, Kjersti Storheim2, Milada C Småstuen3, Margreth Grotle2.   

Abstract

BACKGROUND: The Institute for Medical Technology Assessment Productivity Cost Questionnaire (iPCQ) was recently developed to cover all domains of productivity costs; absenteeism, presenteeism and productivity costs related to unpaid work. The original iPCQ has not been tested with respect to neither content or construct validity, nor reliability, and there is no Norwegian version of the questionnaire.
OBJECTIVES: To translate and cross-culturally adapt the iPCQ into Norwegian and to test its measurement properties among patients with musculoskeletal disorders.
METHODS: Translation and cross-cultural adaptation was conducted according to guidelines, and measurement properties were investigated using a cross-sectional design including a test-retest assessment. Patients with musculoskeletal disorders were recruited from secondary care. Data quality, content validity (10 patients evaluated comprehensibility, 2 researchers and 1 clinician evaluated relevance and comprehensiveness), construct validity (factor analysis, internal consistency, divergent hypothesis testing), and test-retest reliability (intraclass correlation coefficient two-way random average agreement, Cohen's unweighted kappa) were assessed.
RESULTS: In total, 115 patients with a mean age (SD) of 46 (9) years were included, and 62 responded to the retest. The questionnaire was feasible, with little missing data and no floor or ceiling effects. Content validity displayed good comprehensibility and relevance and sufficient comprehensiveness. Factor analysis revealed a 3-component solution accounting for 82% of the total variance; items loaded as expected and supported the original structure of the iPCQ. Internal consistency was acceptable for the 3 components of productivity cost, with an inter-item correlation ranging from 0.42 to 0.62. Further, a total of 91% of our hypotheses were verified. The intraclass correlation coefficient values ranged from 0.88 to 0.99 for all items except one; kappa ranged from 0.61 to 0.92, indicating overall good reliability of the questionnaire.
CONCLUSIONS: The Norwegian iPCQ showed good measurement properties among patients with musculoskeletal disorders from secondary care in Norway. We therefore recommend the iPCQ as a useful tool for measuring productivity costs in patients with musculoskeletal disorders.
Copyright © 2019 ISPOR–The Professional Society for Health Economics and Outcomes Research. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  measurement properties; musculoskeletal disorders; productivity costs

Year:  2019        PMID: 31806198     DOI: 10.1016/j.jval.2019.07.011

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  3 in total

1.  Translation, cross-cultural adaptation and validation of the Computer Vision Syndrome Questionnaire into Persian (CVS-Q FA©).

Authors:  Milad Qolami; Ali Mirzajani; Elena Ronda-Pérez; Natalia Cantó-Sancho; Mar Seguí-Crespo
Journal:  Int Ophthalmol       Date:  2022-05-11       Impact factor: 2.029

2.  Cultural Adaptation and Validation of the Korean Version of the iMTA Productivity Cost Questionnaire.

Authors:  Hyungtae Kim; Kyoung Sun Park; Jeong-Eun Yoo; Siin Kim; Sola Han; Hae Sun Suh
Journal:  Healthcare (Basel)       Date:  2020-06-24

3.  Study protocol for a randomized controlled trial of the effectiveness of adding motivational interviewing or stratified vocational advice intervention to usual case management on return to work for people with musculoskeletal disorders. The MI-NAV study.

Authors:  Britt Elin Øiestad; Fiona Aanesen; Ida Løchting; Kjersti Storheim; Alexander Tingulstad; Tarjei L Rysstad; Milada C Småstuen; Anne Therese Tveter; Gail Sowden; Gwenllian Wynne-Jones; Egil A Fors; Maurits van Tulder; Rigmor C Berg; Nadine E Foster; Margreth Grotle
Journal:  BMC Musculoskelet Disord       Date:  2020-07-28       Impact factor: 2.362

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.